Cargando…

Prognostic value of mean velocity at the pulmonary artery estimated by cardiovascular magnetic resonance as a prognostic predictor in a cohort of patients with new-onset heart failure with reduced ejection fraction

BACKGROUND: Pulmonary hypertension (PH) conveys a worse prognosis in heart failure (HF), in particular when right ventricular (RV) dysfunction ensues. Cardiovascular magnetic resonance (CMR) non-invasively estimates pulmonary vascular resistance (PVR), which has shown prognostic value in HF. Importa...

Descripción completa

Detalles Bibliográficos
Autores principales: Trejo-Velasco, Blanca, Fabregat-Andrés, Óscar, García-González, Pilar M., Perdomo-Londoño, Diana C., Cubillos-Arango, Andrés M., Ferrando-Beltrán, Mónica I., Belchi-Navarro, Joaquina, Pérez-Boscá, José L., Payá-Serrano, Rafael, Ridocci-Soriano, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191770/
https://www.ncbi.nlm.nih.gov/pubmed/32354373
http://dx.doi.org/10.1186/s12968-020-00621-3
_version_ 1783527909491736576
author Trejo-Velasco, Blanca
Fabregat-Andrés, Óscar
García-González, Pilar M.
Perdomo-Londoño, Diana C.
Cubillos-Arango, Andrés M.
Ferrando-Beltrán, Mónica I.
Belchi-Navarro, Joaquina
Pérez-Boscá, José L.
Payá-Serrano, Rafael
Ridocci-Soriano, Francisco
author_facet Trejo-Velasco, Blanca
Fabregat-Andrés, Óscar
García-González, Pilar M.
Perdomo-Londoño, Diana C.
Cubillos-Arango, Andrés M.
Ferrando-Beltrán, Mónica I.
Belchi-Navarro, Joaquina
Pérez-Boscá, José L.
Payá-Serrano, Rafael
Ridocci-Soriano, Francisco
author_sort Trejo-Velasco, Blanca
collection PubMed
description BACKGROUND: Pulmonary hypertension (PH) conveys a worse prognosis in heart failure (HF), in particular when right ventricular (RV) dysfunction ensues. Cardiovascular magnetic resonance (CMR) non-invasively estimates pulmonary vascular resistance (PVR), which has shown prognostic value in HF. Importantly, RV to pulmonary artery (PA) coupling is altered early in HF, before significant rise in PV resistance occurs. The aim of this study was to assess the prognostic value of mean velocity at the pulmonary artery (mvPA), a novel non-invasive parameter determined by CMR, in HF with reduced ejection fraction (HFrEF) with and without associated PH. METHODS: Prospective inclusion of 238 patients admitted for new-onset HFrEF. MvPA was measured with CMR during index admission. The primary endpoint was defined as a composite of HF readmissions and all-cause mortality. RESULTS: During a median follow-up of 25 months, 91 patients presented with the primary endpoint. Optimal cut-off value of mvPA calculated by the receiver operator curve for the prediction of the primary endpoint was 9 cm/s. The primary endpoint occurred more frequently in patients with mvPA≤9 cm/s, as indicated by Kaplan-Meier survival curves; Log Rank 16.0, p <  0.001. Importantly, mvPA maintained its prognostic value regardless of RV function and also when considering mortality and HF readmissions separately. On Cox proportional hazard analysis, reduced mvPA≤9 cm/s emerged as an independent prognostic marker, together with NYHA III-IV/IV class, stage 3–4 renal failure and ischemic cardiomyopathy. CONCLUSIONS: In our HFrEF cohort, mvPA emerged as an independent prognostic indicator independent of RV function, allowing identification of a higher-risk population before structural damage onset. Moreover, mvPA emerged as a surrogate marker of the RV-PA unit coupling status.
format Online
Article
Text
id pubmed-7191770
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-71917702020-05-04 Prognostic value of mean velocity at the pulmonary artery estimated by cardiovascular magnetic resonance as a prognostic predictor in a cohort of patients with new-onset heart failure with reduced ejection fraction Trejo-Velasco, Blanca Fabregat-Andrés, Óscar García-González, Pilar M. Perdomo-Londoño, Diana C. Cubillos-Arango, Andrés M. Ferrando-Beltrán, Mónica I. Belchi-Navarro, Joaquina Pérez-Boscá, José L. Payá-Serrano, Rafael Ridocci-Soriano, Francisco J Cardiovasc Magn Reson Research Article BACKGROUND: Pulmonary hypertension (PH) conveys a worse prognosis in heart failure (HF), in particular when right ventricular (RV) dysfunction ensues. Cardiovascular magnetic resonance (CMR) non-invasively estimates pulmonary vascular resistance (PVR), which has shown prognostic value in HF. Importantly, RV to pulmonary artery (PA) coupling is altered early in HF, before significant rise in PV resistance occurs. The aim of this study was to assess the prognostic value of mean velocity at the pulmonary artery (mvPA), a novel non-invasive parameter determined by CMR, in HF with reduced ejection fraction (HFrEF) with and without associated PH. METHODS: Prospective inclusion of 238 patients admitted for new-onset HFrEF. MvPA was measured with CMR during index admission. The primary endpoint was defined as a composite of HF readmissions and all-cause mortality. RESULTS: During a median follow-up of 25 months, 91 patients presented with the primary endpoint. Optimal cut-off value of mvPA calculated by the receiver operator curve for the prediction of the primary endpoint was 9 cm/s. The primary endpoint occurred more frequently in patients with mvPA≤9 cm/s, as indicated by Kaplan-Meier survival curves; Log Rank 16.0, p <  0.001. Importantly, mvPA maintained its prognostic value regardless of RV function and also when considering mortality and HF readmissions separately. On Cox proportional hazard analysis, reduced mvPA≤9 cm/s emerged as an independent prognostic marker, together with NYHA III-IV/IV class, stage 3–4 renal failure and ischemic cardiomyopathy. CONCLUSIONS: In our HFrEF cohort, mvPA emerged as an independent prognostic indicator independent of RV function, allowing identification of a higher-risk population before structural damage onset. Moreover, mvPA emerged as a surrogate marker of the RV-PA unit coupling status. BioMed Central 2020-04-30 /pmc/articles/PMC7191770/ /pubmed/32354373 http://dx.doi.org/10.1186/s12968-020-00621-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Trejo-Velasco, Blanca
Fabregat-Andrés, Óscar
García-González, Pilar M.
Perdomo-Londoño, Diana C.
Cubillos-Arango, Andrés M.
Ferrando-Beltrán, Mónica I.
Belchi-Navarro, Joaquina
Pérez-Boscá, José L.
Payá-Serrano, Rafael
Ridocci-Soriano, Francisco
Prognostic value of mean velocity at the pulmonary artery estimated by cardiovascular magnetic resonance as a prognostic predictor in a cohort of patients with new-onset heart failure with reduced ejection fraction
title Prognostic value of mean velocity at the pulmonary artery estimated by cardiovascular magnetic resonance as a prognostic predictor in a cohort of patients with new-onset heart failure with reduced ejection fraction
title_full Prognostic value of mean velocity at the pulmonary artery estimated by cardiovascular magnetic resonance as a prognostic predictor in a cohort of patients with new-onset heart failure with reduced ejection fraction
title_fullStr Prognostic value of mean velocity at the pulmonary artery estimated by cardiovascular magnetic resonance as a prognostic predictor in a cohort of patients with new-onset heart failure with reduced ejection fraction
title_full_unstemmed Prognostic value of mean velocity at the pulmonary artery estimated by cardiovascular magnetic resonance as a prognostic predictor in a cohort of patients with new-onset heart failure with reduced ejection fraction
title_short Prognostic value of mean velocity at the pulmonary artery estimated by cardiovascular magnetic resonance as a prognostic predictor in a cohort of patients with new-onset heart failure with reduced ejection fraction
title_sort prognostic value of mean velocity at the pulmonary artery estimated by cardiovascular magnetic resonance as a prognostic predictor in a cohort of patients with new-onset heart failure with reduced ejection fraction
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191770/
https://www.ncbi.nlm.nih.gov/pubmed/32354373
http://dx.doi.org/10.1186/s12968-020-00621-3
work_keys_str_mv AT trejovelascoblanca prognosticvalueofmeanvelocityatthepulmonaryarteryestimatedbycardiovascularmagneticresonanceasaprognosticpredictorinacohortofpatientswithnewonsetheartfailurewithreducedejectionfraction
AT fabregatandresoscar prognosticvalueofmeanvelocityatthepulmonaryarteryestimatedbycardiovascularmagneticresonanceasaprognosticpredictorinacohortofpatientswithnewonsetheartfailurewithreducedejectionfraction
AT garciagonzalezpilarm prognosticvalueofmeanvelocityatthepulmonaryarteryestimatedbycardiovascularmagneticresonanceasaprognosticpredictorinacohortofpatientswithnewonsetheartfailurewithreducedejectionfraction
AT perdomolondonodianac prognosticvalueofmeanvelocityatthepulmonaryarteryestimatedbycardiovascularmagneticresonanceasaprognosticpredictorinacohortofpatientswithnewonsetheartfailurewithreducedejectionfraction
AT cubillosarangoandresm prognosticvalueofmeanvelocityatthepulmonaryarteryestimatedbycardiovascularmagneticresonanceasaprognosticpredictorinacohortofpatientswithnewonsetheartfailurewithreducedejectionfraction
AT ferrandobeltranmonicai prognosticvalueofmeanvelocityatthepulmonaryarteryestimatedbycardiovascularmagneticresonanceasaprognosticpredictorinacohortofpatientswithnewonsetheartfailurewithreducedejectionfraction
AT belchinavarrojoaquina prognosticvalueofmeanvelocityatthepulmonaryarteryestimatedbycardiovascularmagneticresonanceasaprognosticpredictorinacohortofpatientswithnewonsetheartfailurewithreducedejectionfraction
AT perezboscajosel prognosticvalueofmeanvelocityatthepulmonaryarteryestimatedbycardiovascularmagneticresonanceasaprognosticpredictorinacohortofpatientswithnewonsetheartfailurewithreducedejectionfraction
AT payaserranorafael prognosticvalueofmeanvelocityatthepulmonaryarteryestimatedbycardiovascularmagneticresonanceasaprognosticpredictorinacohortofpatientswithnewonsetheartfailurewithreducedejectionfraction
AT ridoccisorianofrancisco prognosticvalueofmeanvelocityatthepulmonaryarteryestimatedbycardiovascularmagneticresonanceasaprognosticpredictorinacohortofpatientswithnewonsetheartfailurewithreducedejectionfraction